16,117 iShares Biotechnology ETF $IBB Shares Acquired by Kestra Advisory Services LLC

Kestra Advisory Services LLC increased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 34.1% during the third quarter, Holdings Channel reports. The fund owned 63,312 shares of the financial services provider’s stock after purchasing an additional 16,117 shares during the period. Kestra Advisory Services LLC’s holdings in iShares Biotechnology ETF were worth $13,329,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Bank of America Corp DE raised its position in iShares Biotechnology ETF by 10.8% in the 1st quarter. Bank of America Corp DE now owns 7,259,501 shares of the financial services provider’s stock valued at $1,225,767,000 after purchasing an additional 707,343 shares during the last quarter. Royal Bank of Canada boosted its stake in iShares Biotechnology ETF by 1.0% in the first quarter. Royal Bank of Canada now owns 737,128 shares of the financial services provider’s stock worth $124,464,000 after purchasing an additional 7,434 shares in the last quarter. Commonwealth Equity Services LLC boosted its stake in iShares Biotechnology ETF by 1.3% in the third quarter. Commonwealth Equity Services LLC now owns 139,653 shares of the financial services provider’s stock worth $29,401,000 after purchasing an additional 1,819 shares in the last quarter. Albion Financial Group UT grew its holdings in shares of iShares Biotechnology ETF by 1.0% during the third quarter. Albion Financial Group UT now owns 120,782 shares of the financial services provider’s stock worth $25,428,000 after purchasing an additional 1,147 shares during the last quarter. Finally, Cetera Investment Advisers grew its holdings in shares of iShares Biotechnology ETF by 9.4% during the first quarter. Cetera Investment Advisers now owns 128,530 shares of the financial services provider’s stock worth $21,702,000 after purchasing an additional 10,994 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $213.63 on Monday. iShares Biotechnology ETF has a 52 week low of $154.98 and a 52 week high of $222.29. The stock has a market capitalization of $11.14 billion, a PE ratio of 26.08 and a beta of 0.72. The stock’s fifty day moving average is $208.46 and its 200-day moving average is $185.91.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Tuesday, September 15th were given a dividend of $0.0112 per share. This is a negative change from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date was Tuesday, September 15th. This represents a $0.04 annualized dividend and a yield of 0.0%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.